Samsung Bioepis

E850006

Samsung Bioepis is a South Korean biopharmaceutical company specializing in the development and commercialization of biosimilar medicines.

All labels observed (1)

Label Occurrences
Samsung Bioepis canonical 2

How this entity was disambiguated

Statements (48)

Predicate Object
instanceOf biopharmaceutical company
biosimilar manufacturer
businessModel commercialization of biosimilars
development of biosimilars
collaboratesWith Biogen
Biogen Idec
linked to: Biogen

Merck & Co.
Organon
country South Korea
focusesOn diabetes
immunology
oncology
ophthalmology
followsRegulatoryGuidelinesOf European Medicines Agency
U.S. Food and Drug Administration
foundedAsJointVentureWith Biogen
hasOfficialWebsite https://www.samsungbioepis.com
hasProduct Amelivu
Aybintio
Benepali
Flixabi
Hadlima
Imraldi
Ontruzant
Renflexis
hasProductType adalimumab biosimilar
bevacizumab biosimilar
etanercept biosimilar
infliximab biosimilar
insulin glargine biosimilar
trastuzumab biosimilar
hasResearchAndDevelopmentCenterIn Incheon
headquartersLocation Incheon
Songdo International Business District
industry biopharmaceutical
biotechnology
pharmaceutical
languageOfName Korean
parentOrganization Samsung Biologics
Samsung Group
partOf Samsung Life Science business
regulatoryApprovalIn Australia
Canada
European Union
South Korea
United States
specializesIn biologic medicines
biosimilars

How these facts were elicited

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.

Renflexis isManufacturedBy Samsung Bioepis
Samsung Group hasSubsidiary Samsung Bioepis